Cognitive Health References

Cognitive Function Refs

1. Lau FC et al. "The beneficial effects of fruit polyphenols on brain aging." Neurobiol Aging. 26, Suppl 1:128-32, 2005. www.elsevier.com

2. Rinaldi P et al. "Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease." Neurobiol Aging. 24, 7:915-9, 2003. www.elsevier.com

3. Gray SL et al. "Is antioxidant use protective of cognitive function in the community-dwelling elderly?" Am J Geriatr Pharmacother. 1, 1:3-10, 2003. www.elsevier.com

4. Landmark K. "[Could intake of vitamins C and E inhibit development of Alzheimer dementia?]" Tidsskr Nor Laegeforen. 126, 2:159-61, 2006. www.tidsskriftet.no

5. Conte V et al. "Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury." J Neurochem. 90, 3:758-64, 2004. www.blackwell-synergy.com

6. Cherubini A et al. "Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study." Neurobiol Aging. 26 7:987-94, 2005. www.elsevier.com

7. Morris MC et al. "Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change." Am J Clin Nutr. 81, 2:508-14, 2005. www.ajcn.org

8. Sen CK et al. "Tocotrienol potently inhibits glutamate-induced pp60 c-src kinase activation and death of HT4 neuronal cells - Molecular basis of Vitamin E action." J Biol Chem. 275, 17:13049-55, 2000. www.jbc.org

9. Sen CK et al. "Vitamin E sensitive genes in the developing rat fetal brain: a high density oligonucleotide microarray analysis." FEBS Lett. 530:17-23, 2002.

10. Sen CK et al. "Tocotrienol – The natural vitamin E to defend the nervous system." Ann N Y Acad Sci. 1031:1-16, 2004.

11. Sen CK et al. "Vitamin E sensitive genes in the developing rat fetal brain: a high density oligonucleotide microarray analysis." FEBS Lett. 530:17-23, 2002.

12. Sen CK et al. "Neuroprotective Properties of the Natural Vitamin E Alpha-Tocotrienol." Stroke. 36:e144-52, 2005.

13. Chuang YC. " Neuroprotective effects of coenzyme Q10 at rostral ventrolateral medulla against fatality during experimental endotoxemia in the rat." Shock. 19, 5:427-32, 2003. www.shockjournal.com

14. Willis R et al. "Clinical implications of the correlation between coenzyme Q10 and vitamin B6 status." Biofactors. 9, 2-4:359-63, 1999. http://iospress.metapress.com/

15. Beal MF et al. "Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment." J Bioenerg Biomembr. 36, 4:381-6, 2004. www.springerlink.com

16. Moreira PI et al. "CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats." Exp Neurol. 196, 1:112-9, 2005. www.elsevier.com

17. McDonald SR et al. "Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice." Free Radic Biol Med. 38, 6:729-36, 2005. www.elsevier.com

18. Cohen JT et al. "A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development." Am J Prev Med. 29, 4:366-74, 2005. www.elsevier.com

19. Colombo J et al. "Maternal DHA and the development of attention in infancy and toddlerhood." Child Dev. 75, 4:1254-67, 2004. www.blackwell-synergy.com

20. Helland HB et al. "Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age." Pediatrics. 111, 1:e39-44, 2003.

21. McCann JC et al. "An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring." Neurosci Biobehav Rev. 30 5:696-712, 2006. www.elsevier.com

22. Conant R et al. "Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature." Altern Med Rev. 9 1:17-31, 2004. www.thorne.com

23. Fioravanti M et al. "Cytidinediphosphocholine CDP-choline for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly." Cochrane Database Syst Rev. 2:CD000269, 2005. www.mrw.interscience.wiley.com

24. Teather LA et al. "Dietary CDP-choline supplementation prevents memory impairment caused by impoverished environmental conditions in rats." Learn Mem. 12, 1:39-43, 2005. www.learnmem.org

25. Suzuki S et al. "Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats." J Nutr. 131, 11:2951-6, 2001. www.nutrition.org

26. Schreiber S et al. "An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline." Isr J Psychiatry Relat Sci. 37, 4:302-7, 2000.

27. Blokland A et al. "Cognition-enhancing properties of subchronic phosphatidylserine PS treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS." Nutrition. 15, 10:778-83, 1999. www.elsevier.com

28. Wang R et al. "Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease." Neurosignals. 14, 1-2:71-82, 2005. http://content.karger.com

29. Zangara A et al. "The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease." Pharmacol Biochem Behav. 75, 3:675-86, 2003. www.elsevier.com

30. Wang LS et al. "Huperzine A attenuates cognitive deficits and brain injury after hypoxia-ischemic brain damage in neonatal rats]." Zhonghua Er Ke Za Zhi. 41 1:42-5, 2003.

31. Zhou J et al. "Huperzine A attenuates cognitive deficits and hippocampal neuronal damage after transient global ischemia in gerbils." Neurosci Lett. 313, 3:137-40, 2001. www.elsevier.com

32. Tamaki N. et al. "Effect of Vinpocetine on Cerebral Blood flow in patients with cerebrovascular disorders." Advances in Therapy. 2, 53-59, 1985.

33. Vas A et al. "Eburnamine derivatives and the brain." Med Res Rev. 25, 6:737-57, 2005.

34. Rischke R et al. "Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat." Pharmacology. 41, 3:153-60, 1990.

35. Kuzuya F et al. "Effects of vinpocetine on platelet aggregability and erythrocyte deformability." Therapia Hungarica. 33, 22-34, 1985 .

36. Szilagyi G et al. "Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study." J Neurol Sci. 229-30:275-84, 2005.

37. Andres-Lacueva C et al. "Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory." Nutr Neurosci. 8, 2:111-20, 2005.

38. Casadesus G et al. "Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats." Nutr Neurosci. 7, 5-6:309-16, 2004.

39. Joseph JA et al. "Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation." J Neurosci. 19, 18:8114-21, 1999. www.jneurosci.org

40. Ramirez MR et al. "Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats." Phararmacol Res. 52, 6:457-62, 2005. www.elsevier.com

41. Kolosova NG et al. "Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats." Neurobiol Aging. Oct 20, 2005; [Epub ahead of print] www.elsevier.com

42. Stromberg I et al. "Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system." Exp Neurol. 196, 2:298-307, 2005. Epub 2005 Sep 19. www.elsevier.com

43. Wang Y et al. "Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage." Exp Neurol. 193, 1:75-84, 2005. www.elsevier.com

44. Peng QL et al. "Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis." Brain Res Mol Brain Res. 104, 1:55-65, 2002. www.elsevier.com

45. Siler-Marsiglio KI et al. "Pycnogenol and vitamin E inhibit ethanol-induced apoptosis in rat cerebellar granule cells." J Neurobiol. 59, 3:261-71, 2004. www.mrw.interscience.wiley.com

46. Mandel SA et al. "Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway." Neurosignals. 14 1-2:46-60, 2005. http://content.karger.com

47. Haque AM et al. "Long-term administration of green tea catechins improves spatial cognition learning ability in rats." J Nutr. 136, 4:1043-7, 2006. www.nutrition.org

48. Kuriyama S et al. "Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1." Am J Clin Nutr. 83, 2:355-61, 2006. www.ajcn.org

49. Duffy R et al. "Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones." Pharmacol Biochem Behav. 75 3:721-9, 2003. www.elsevier.com

50. Kritz-Silverstein D et al. "Isoflavones and cognitive function in older women: the Soy and Postmenopausal Health In Aging SOPHIA Study." Menopause. 10, 3:196-202, 2003. www.menopausejournal.com

51. Sharma M et al. "Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats." Life Sci. 71, 21:2489-98, 2002. www.elsevier.com

52. Lu KT et al. "Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation." J Agric Food Chem. 54, 8:3126-31, 2006. http://pubs.acs.org/journals/jafcau/index.html

53. Baum L et al. "Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models." J Alzheimers Dis. 6 4:367-77, 2004. http://iospress.metapress.com

54. Yang F et al. "Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo." J Biol Chem. 280, 7:5892-901, 2005. www.jbc.org

55. Wu A et al."Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition." Exp Neurol. 197 2:309-17, 2006. www.elsevier.com

56. Reay JL et al. "Single doses of Panax ginseng G115 reduce blood glucose levels and improve cognitive performance during sustained mental activity." J Psychopharmacol. 19 4:357-65, 2005. http://jop.sagepub.com/

57. Rudakewich M et al. "Neurotrophic and neuroprotective actions of ginsenosides Rb 1 and Rg 1." Planta Med. 67, 6:533-7, 2001. www.thieme-connect.com

58. Kuboyama T et al. "Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha." Neuroreport. 13, 14:1715-20, 2002. www.lwwonline.com

59. Tohda C et al. "Dendrite extension by methanol extract of Ashwagandha roots of Withania somnifera in SK-N-SH cells." Neuroreport. 11, 9:1981-5, 2000. www.lwwonline.com

60. Kuboyama T et al. "Withanoside IV and its active metabolite, sominone, attenuate Abeta 25-35 -induced neurodegeneration." Eur J Neurosci. 23, 6:1417-26, 2006. www.blackwell-synergy.com

61. Kuboyama T et al. "Neuritic regeneration and synaptic reconstruction induced by withanolide A." Br J Pharmacol. 144, 7:961-71, 2005. www.nature.com/bjp

62. Vohora D et al. "Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant." J Ethnopharmacol. 71, 3:383-90, 2000. www.elsevier.com

62. Stough C et al. "The chronic effects of an extract of Bacopa monniera Brahmi on cognitive function in healthy human subjects." Psychopharmacology Berl. 156, 4:481-4, 2001. www.springerlink.com

63. Vohora D et al. "Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant." J Ethnopharmacol. 71, 3:383-90, 2000. www.elsevier.com

64. Das A et al. "A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities." Pharmacol Biochem Behav. 73, 4:893-900, 2002. www.elsevier.com

65. Walesiuk A et al. "Ginkgo biloba normalizes stress- and corticosterone-induced impairment of recall in rats." Pharmacol Res. 53, 2:123-8, 2006. www.elsevier.com

66. Walesiuk A et al. "Gingko biloba extract diminishes stress-induced memory deficits in rats." Pharmacol Rep. 57, 2:176-87, 2005. www.if-pan.krakow.pl

67. Yao ZX et al. "Ginkgo biloba extract Egb 761 inhibits beta-amyloid production by lowering free cholesterol levels." J Nutr Biochem. 15, 12:749-56, 2004. www.elsevier.com

68. Wang Y et al. "The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats." Br J Pharmacol. 148, 2:147-53, 2006. www.nature.com/bjp

69. Zhang M et al. "Extract of Ginkgo biloba leaves reverses yohimbine-induced spatial working memory deficit in rats." Behav Pharmacol. 16, 8:651-6, 2005. www.behaviouralpharm.com

70. Dekosky ST et al. "The Ginkgo Evaluation of Memory GEM study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia." Contemp Clin Trials. 27, 3:238-53, 2006. www.elsevier.com

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines